Page last updated: 2024-10-25

ciprofloxacin and Cane-Cutter Fever

ciprofloxacin has been researched along with Cane-Cutter Fever in 7 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
" Many antibiotics at appropriate concentrations improved the survival rate and alleviated tissue injury, while, when dosing strategies fall below subtherapeutic levels, worse therapeutic effects are seen."5.46Low-dose norfloxacin and ciprofloxacin therapy worsen leptospirosis in hamster. ( Cao, Y; Guo, J; Jin, X; Lin, T; Wang, T; Wu, D; Wu, R; Xie, X; Zhang, W, 2017)
" Many antibiotics at appropriate concentrations improved the survival rate and alleviated tissue injury, while, when dosing strategies fall below subtherapeutic levels, worse therapeutic effects are seen."1.46Low-dose norfloxacin and ciprofloxacin therapy worsen leptospirosis in hamster. ( Cao, Y; Guo, J; Jin, X; Lin, T; Wang, T; Wu, D; Wu, R; Xie, X; Zhang, W, 2017)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffith, ME2
Moon, JE1
Johnson, EN1
Clark, KP1
Hawley, JS1
Hospenthal, DR2
Murray, CK2
Ressner, RA1
Beckius, ML1
Pimentel, G1
Miller, RS1
Mende, K1
Fraser, SL1
Galloway, RL1
Arnold, C1
Boss, J1
Dance, DAB1
Chanthongthip, A1
Newton, PN1
Wuthiekanun, V1
Robinson, MT1
Wu, D1
Zhang, W1
Wang, T1
Lin, T1
Jin, X1
Xie, X1
Guo, J1
Cao, Y1
Wu, R1
Sugunan, AP1
Natarajaseenivasan, K1
Vijayachari, P1
Sehgal, SC1
Bal, AM1

Other Studies

7 other studies available for ciprofloxacin and Cane-Cutter Fever

ArticleYear
Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cricetinae; Disease Models, Animal; Do

2007
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins;

2008
Source code: Putting metagenomics to the test in the clinic.
    Nature medicine, 2017, 06-06, Volume: 23, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Humans; Immunologic Deficiency Syndromes; Leptospi

2017
Antimicrobial Susceptibility Testing of
    The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:5

    Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Culture Media; Disk Diffusion Antimicrobia

2019
Low-dose norfloxacin and ciprofloxacin therapy worsen leptospirosis in hamster.
    Microbial pathogenesis, 2017, Volume: 102

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biopsy; Ciprofloxacin; Cricetinae; Cytokines; Diseas

2017
Percutaneous exposure resulting in laboratory-acquired leptospirosis -- a case report.
    Journal of medical microbiology, 2004, Volume: 53, Issue:Pt 12

    Topics: Adult; Anti-Infective Agents; Ciprofloxacin; DNA Fingerprinting; Doxycycline; Hand Injuries; Humans;

2004
Use of ciprofloxacin for treating leptospirosis--need for clinical trials.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 9

    Topics: Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Humans; Leptospirosis

2005